haloperidol and bupropion

haloperidol has been researched along with bupropion in 34 studies

Research

Studies (34)

TimeframeStudies, this research(%)All Research%
pre-19906 (17.65)18.7374
1990's4 (11.76)18.2507
2000's9 (26.47)29.6817
2010's15 (44.12)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL1
Bleich, S; Gulbins, E; Kornhuber, J; Reichel, M; Terfloth, L; Tripal, P; Wiltfang, J1
Artursson, P; Bergström, CA; Hoogstraate, J; Matsson, P; Norinder, U; Pedersen, JM1
Ahman, M; Holmén, AG; Wan, H1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Glen, RC; Lowe, R; Mitchell, JB1
Boriss, H; Braggio, S; Corbioli, S; Fontana, S; Helmdach, L; Longhi, R; Schiller, J; Vinco, F1
Annand, R; Gozalbes, R; Jacewicz, M; Pineda-Lucena, A; Tsaioun, K1
Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V1
Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ1
Dalvie, D; Loi, CM; Smith, DA1
Bellman, K; Knegtel, RM; Settimo, L1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Jones, LH; Nadanaciva, S; Rana, P; Will, Y1
Brown, EE; Cumming, P; Damsma, G; Fibiger, HC1
Balsara, JJ; Kop, PB; Muley, MP1
Loskutova, LV; Luk'ianenko, FIa1
Bergman, J; Spealman, RD1
Dahms, JL; Seiden, LS; Shaughnessy, RA1
Trulson, ME1
Ortmann, R1
Goode, DJ; Manning, AA1
Carter, RG; Manberg, PJ1
Gazzara, RA; Gough, B; Holson, RR1
Admiraal, P; de Graaf, L; van Puijenbroek, EP1
Kalgutkar, AS; Nguyen, HT1
Gur, RE; Kanes, SJ; Lerman, C; Liang, Y; Majumdar, S; Maxwell, CR; Siegel, SJ; Trief, DF1
Gerak, LR; Moerschbaecher, JM; Quinton, MS; Winsauer, PJ1
Harvey, I; Lilford, R; Song, F1
Lipina, T; Roder, J1
Balci, F; Campbell, U; Hanania, T; Olivier, BE; Paterson, NE1
Collins, SL; Contreras-Mora, HM; Correa, M; Errante, EL; Rowland, MA; Salamone, JD; Yohn, SE1
Boušová, I; Matoušková, P; Skálová, L; Souček, P1
McAllister, MW; Woodhall, DM1

Reviews

3 review(s) available for haloperidol and bupropion

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016
Adjusted indirect comparison may be less biased than direct comparison for evaluating new pharmaceutical interventions.
    Journal of clinical epidemiology, 2008, Volume: 61, Issue:5

    Topics: Antidepressive Agents, Second-Generation; Antipsychotic Agents; Bias; Bupropion; Data Interpretation, Statistical; Drug Therapy; Fluoxetine; Haloperidol; Humans; Imipramine; Meta-Analysis as Topic; Nicotine; Randomized Controlled Trials as Topic; Risperidone; Schizophrenia; Smoking Cessation; Treatment Outcome

2008
The modulation of carbonyl reductase 1 by polyphenols.
    Drug metabolism reviews, 2015, Volume: 47, Issue:4

    Topics: Alcohol Oxidoreductases; Animals; Bupropion; Butanones; Butyrophenones; Daunorubicin; Doxorubicin; Gene Expression Regulation, Enzymologic; Haloperidol; Humans; Indoles; Nabumetone; Neoplasms; Phenylpropionates; Polyphenols; Quinolizines; Substrate Specificity; Xenobiotics

2015

Trials

1 trial(s) available for haloperidol and bupropion

ArticleYear
Comparison of bupropion alone and with haloperidol in schizo-affective disorder, depressed type.
    The Journal of clinical psychiatry, 1983, Volume: 44, Issue:7

    Topics: Adolescent; Adult; Bupropion; Depressive Disorder; Drug Therapy, Combination; Female; Haloperidol; Humans; Male; Outcome and Process Assessment, Health Care; Propiophenones; Psychiatric Status Rating Scales; Psychotic Disorders

1983

Other Studies

30 other study(ies) available for haloperidol and bupropion

ArticleYear
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
    Current drug discovery technologies, 2004, Volume: 1, Issue:4

    Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration

2004
Identification of new functional inhibitors of acid sphingomyelinase using a structure-property-activity relation model.
    Journal of medicinal chemistry, 2008, Jan-24, Volume: 51, Issue:2

    Topics: Algorithms; Animals; Cell Line; Cell Line, Tumor; Chemical Phenomena; Chemistry, Physical; Enzyme Inhibitors; Humans; Hydrogen-Ion Concentration; Molecular Conformation; Quantitative Structure-Activity Relationship; Rats; Sphingomyelin Phosphodiesterase

2008
Prediction and identification of drug interactions with the human ATP-binding cassette transporter multidrug-resistance associated protein 2 (MRP2; ABCC2).
    Journal of medicinal chemistry, 2008, Jun-12, Volume: 51, Issue:11

    Topics: Administration, Oral; Animals; Antineoplastic Agents; Antipsychotic Agents; Antiviral Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Biological Transport; Cell Line; Computer Simulation; Cytochrome P-450 Enzyme System; Drug-Related Side Effects and Adverse Reactions; Estradiol; Humans; Insecta; Liver; Models, Molecular; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Pharmaceutical Preparations; Pharmacology; Structure-Activity Relationship

2008
Relationship between brain tissue partitioning and microemulsion retention factors of CNS drugs.
    Journal of medicinal chemistry, 2009, Mar-26, Volume: 52, Issue:6

    Topics: Brain; Central Nervous System; Chromatography, Liquid; Emulsions; Mass Spectrometry

2009
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
Predicting phospholipidosis using machine learning.
    Molecular pharmaceutics, 2010, Oct-04, Volume: 7, Issue:5

    Topics: Animals; Artificial Intelligence; Databases, Factual; Drug Discovery; Humans; Lipidoses; Models, Biological; Phospholipids; Support Vector Machine

2010
Brain tissue binding of drugs: evaluation and validation of solid supported porcine brain membrane vesicles (TRANSIL) as a novel high-throughput method.
    Drug metabolism and disposition: the biological fate of chemicals, 2011, Volume: 39, Issue:2

    Topics: Absorption; Albumins; Animals; Brain; Brain Chemistry; Cell Membrane; Chromatography, High Pressure Liquid; Drug Evaluation, Preclinical; In Vitro Techniques; Lipids; Male; Microdialysis; Pharmaceutical Preparations; Protein Binding; Rats; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Swine; Tissue Distribution

2011
QSAR-based permeability model for drug-like compounds.
    Bioorganic & medicinal chemistry, 2011, Apr-15, Volume: 19, Issue:8

    Topics: Caco-2 Cells; Cell Membrane Permeability; Drug Discovery; Humans; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship

2011
FDA-approved drug labeling for the study of drug-induced liver injury.
    Drug discovery today, 2011, Volume: 16, Issue:15-16

    Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration

2011
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
    Drug metabolism and disposition: the biological fate of chemicals, 2012, Volume: 40, Issue:12

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship

2012
Which metabolites circulate?
    Drug metabolism and disposition: the biological fate of chemicals, 2013, Volume: 41, Issue:5

    Topics: Humans; Metabolic Clearance Rate; Pharmaceutical Preparations

2013
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds.
    Pharmaceutical research, 2014, Volume: 31, Issue:4

    Topics: Chemistry, Pharmaceutical; Forecasting; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Random Allocation

2014
Development of a cell viability assay to assess drug metabolite structure-toxicity relationships.
    Bioorganic & medicinal chemistry letters, 2016, 08-15, Volume: 26, Issue:16

    Topics: Adenosine Triphosphate; Benzbromarone; Cell Line; Cell Survival; Chromans; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Humans; Pharmaceutical Preparations; Thiazolidinediones; Troglitazone

2016
Interstitial 3-methoxytyramine reflects striatal dopamine release: an in vivo microdialysis study.
    Journal of neurochemistry, 1991, Volume: 57, Issue:2

    Topics: 3,4-Dihydroxyphenylacetic Acid; 4-Butyrolactone; Animals; Antidepressive Agents; Apomorphine; Bupropion; Corpus Striatum; Dialysis; Dopamine; Haloperidol; Homovanillic Acid; Kinetics; Male; Propiophenones; Rats; Rats, Inbred Strains; Tetrodotoxin

1991
Differential effect of bupropion on haloperidol and morphine catalepsy in the rat.
    Indian journal of physiology and pharmacology, 1990, Volume: 34, Issue:3

    Topics: Animals; Antidepressive Agents; Bupropion; Catalepsy; Female; Haloperidol; Male; Morphine; Propiophenones; Rats

1990
[Specifics of participation of dopaminergic and serotoninergic systems of the brain in latent inhibition based on pharmacological models].
    Biulleten' eksperimental'noi biologii i meditsiny, 1990, Volume: 110, Issue:12

    Topics: 1-Naphthylamine; Animals; Antidepressive Agents; Avoidance Learning; Brain; Bupropion; Dopamine; Haloperidol; Male; Propiophenones; Rats; Rats, Inbred Strains; Serotonin; Serotonin Antagonists; Sertraline

1990
Behavioral effects of histamine H1 antagonists: comparison with other drugs and modification by haloperidol.
    The Journal of pharmacology and experimental therapeutics, 1988, Volume: 245, Issue:2

    Topics: Animals; Bupropion; Cocaine; Conditioning, Operant; Cyproheptadine; Desipramine; Diazepam; Dose-Response Relationship, Drug; Electroshock; Haloperidol; Histamine H1 Antagonists; Male; Propiophenones; Saimiri

1988
Behavioral screen for antidepressants: the effects of drugs and electroconvulsive shock on performance under a differential-reinforcement-of-low-rate schedule.
    Psychopharmacology, 1985, Volume: 86, Issue:1-2

    Topics: Animals; Antidepressive Agents; Bupropion; Clozapine; Drug Evaluation, Preclinical; Electroshock; Fluoxetine; Haloperidol; Male; Propiophenones; Rats; Rats, Inbred Strains; Reinforcement Schedule; Trazodone; Zimeldine

1985
Activity of dopamine-containing substantia nigra neurons in freely moving cats.
    Neuroscience and biobehavioral reviews, 1985,Summer, Volume: 9, Issue:2

    Topics: Action Potentials; Animals; Apomorphine; Brain Mapping; Bupropion; Cats; Circadian Rhythm; Dextroamphetamine; Dopamine; Female; Haloperidol; Lysergic Acid Diethylamide; Male; Propiophenones; Sensation; Sleep Stages; Substantia Nigra

1985
The conditioned place preference paradigm in rats: effect of bupropion.
    Life sciences, 1985, Nov-25, Volume: 37, Issue:21

    Topics: Animals; Bupropion; Conditioning, Psychological; Haloperidol; Male; Motor Activity; Propiophenones; Rats; Sulpiride

1985
Bupropion in the treatment of psychotic depression: two case reports.
    The Journal of clinical psychiatry, 1984, Volume: 45, Issue:5

    Topics: Adult; Antidepressive Agents; Bupropion; Depressive Disorder; Drug Therapy, Combination; Female; Haloperidol; Humans; Middle Aged; Propiophenones; Recurrence

1984
Declines in stimulated striatal dopamine release over the first 32 h following microdialysis probe insertion: generalization across releasing mechanisms.
    Brain research, 1998, Oct-19, Volume: 808, Issue:2

    Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Axotomy; Bupropion; Corpus Striatum; Dopamine; Dopamine Antagonists; Dopamine Uptake Inhibitors; Haloperidol; Male; Microdialysis; Potassium; Rats; Rats, Sprague-Dawley; Time Factors

1998
Ballism associated with bupropion use.
    The Annals of pharmacotherapy, 2003, Volume: 37, Issue:2

    Topics: Adult; Bupropion; Dyskinesia, Drug-Induced; Female; Haloperidol; Humans; Oxazepam

2003
Identification of an N-methyl-4-phenylpyridinium-like metabolite of the antidiarrheal agent loperamide in human liver microsomes: underlying reason(s) for the lack of neurotoxicity despite the bioactivation event.
    Drug metabolism and disposition: the biological fate of chemicals, 2004, Volume: 32, Issue:9

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 1-Methyl-4-phenylpyridinium; Animals; Antidiarrheals; Bupropion; Chromatography, High Pressure Liquid; Cytochrome P-450 Enzyme System; Dealkylation; Haloperidol; Humans; Hydroxylation; Ketoconazole; Loperamide; Male; Microsomes, Liver; NADP; Neurons; Pyridinium Compounds; Rats; Rats, Sprague-Dawley; Time Factors

2004
Monoamine reuptake inhibition and nicotine receptor antagonism reduce amplitude and gating of auditory evoked potentials.
    Neuroscience, 2005, Volume: 133, Issue:3

    Topics: Animals; Antipsychotic Agents; Biogenic Monoamines; Bupropion; Disease Models, Animal; Dopamine Uptake Inhibitors; Drug Therapy, Combination; Evoked Potentials, Auditory; Haloperidol; Male; Mice; Mice, Inbred C57BL; Nicotine; Nicotinic Agonists; Nicotinic Antagonists; Receptors, Nicotinic; Schizophrenia

2005
Effects of pregnanolone in rats discriminating cocaine.
    Pharmacology, biochemistry, and behavior, 2006, Volume: 85, Issue:2

    Topics: Animals; Bupropion; Cocaine; Desipramine; Dextroamphetamine; Discrimination Learning; Dose-Response Relationship, Drug; Haloperidol; Male; Pregnanolone; Rats; Rats, Long-Evans; Receptors, GABA-A

2006
A new model of the disrupted latent inhibition in C57BL/6J mice after bupropion treatment.
    Psychopharmacology, 2010, Volume: 208, Issue:3

    Topics: Amphetamine; Animals; Bupropion; Clozapine; Conditioning, Psychological; Disease Models, Animal; Dopamine Agonists; Dopamine Uptake Inhibitors; Drug Interactions; Haloperidol; Inhibition, Psychological; Male; Mice; Mice, Inbred C57BL; Neural Inhibition; Phosphodiesterase 4 Inhibitors; Piperazines; Rolipram; Schizophrenic Psychology

2010
The triple reuptake inhibitor DOV216,303 exhibits limited antidepressant-like properties in the differential reinforcement of low-rate 72-second responding assay, likely due to dopamine reuptake inhibition.
    Journal of psychopharmacology (Oxford, England), 2011, Volume: 25, Issue:10

    Topics: Animals; Antidepressive Agents; Aza Compounds; Bridged Bicyclo Compounds, Heterocyclic; Bupropion; Desipramine; Diazepam; Dopamine Uptake Inhibitors; Fluvoxamine; Haloperidol; Imipramine; Male; Piperazines; Rats; Rats, Sprague-Dawley; Reinforcement, Psychology

2011
Not All Antidepressants Are Created Equal: Differential Effects of Monoamine Uptake Inhibitors on Effort-Related Choice Behavior.
    Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2016, Volume: 41, Issue:3

    Topics: Animals; Antidepressive Agents; Benzazepines; Bupropion; Choice Behavior; Desipramine; Dopamine Antagonists; Dose-Response Relationship, Drug; Fluoxetine; Haloperidol; Male; Motivation; Neurotransmitter Uptake Inhibitors; Piperazines; Rats, Sprague-Dawley; Tetrabenazine; Vesicular Monoamine Transport Proteins

2016
Bupropion-induced stuttering treated with haloperidol.
    Clinical toxicology (Philadelphia, Pa.), 2016, Volume: 54, Issue:7

    Topics: Bupropion; Emergency Service, Hospital; Haloperidol; Humans; Male; Middle Aged; Stuttering

2016